Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...

Zydus Cadila has filed for emergency use approval (EUA) in India of its plasmid DNA-based vaccine for COVID-19, which if given a green light could become the first shot of its type to be cleared ...

New Delhi, Mar 5 () Zydus Cadila has received approval from the Drug Controller General of India (DCGI) for its new drug application for Saroglitazar to treat a particular condition of liver ...

Indian drugmaker Zydus Cadila announced on Thursday that it has applied for Emergency Use Authorisation (EUA) to the country's regulator for ZyCoV-D- its COVID-19 vaccine for those aged 12 years ...

Zydus Lifesciences announced that Usnoflast, a treatment for amyotrophic lateral sclerosis (ALS), has received Orphan Drug Designation from the US FDA. This designation supports the development of ...

Indian vaccine makers, Bharat Biotech and Zydus Cadila, must publish studies on the efficacy of their vaccines in relation to the Omicron variant. ZY-19489 is a potential single dose radical cure ...

Learn about Zydus Cadila Health Care Limited in Goa.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...

Learn about Zydus Cadila Healthcare Ltd. in Ahmedabad, Gujarat.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or ...

Iram Sultan Design Studio has designed a workplace for pharmaceutical company Zydus Cadila in Gujarat, India. The studio's designs are inspired by the context and the client. The office floor for ...

Zydus Lifesciences announced that it has entered into an agreement with CVS Caremark, a CVS Health (CVS) company, to add Zituvio, Zituvimet and Zituvimet XR tablets to its template formulary.

Zydus Lifesciences Ltd enters an agreement with CVS Caremark to add Zituvio, Zituvimet, and Zituvimet XR tablets for diabetes treatment to CVS’s template formulary starting January 1, 2025. This ...